Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs
- 29 October 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 9 (2) , 267-286
Abstract
SummaryData from cross-sectional and prospective studies revealed that patients with epilepsy and on long-term treatment with antiepileptic drugs (AEDs) are at increased risk for metabolic bone diseases. Bone diseases were reported in about 50% of patients on AEDs. Low bone mineral density, osteopenia/osteoporosis, osteomalacia, rickets, altered concentration of bone turnover markers and fractures were reported with phenobarbital, phenytoin, carbamazepine, valproate, oxcarbazepine and lamotrigine. The mechanisms for AEDs–induced bone diseases are heterogeneous and include hypovitaminosis D, hypocalcemia and direct acceleration of bone loss and/or reduction of bone formation. This article reviews the evidence, predictors and mechanisms of AEDs-induced bone abnormalities and its clinical implications. For patients on AEDs, regular monitoring of bone health is recommended. Prophylactic administration of calcium and vitamin D is recommended for all patients. Treatment doses of calcium and vitamin D and even a...Keywords
This publication has 147 references indexed in Scilit:
- Biomarkers of bone health and osteoporosis riskProceedings of the Nutrition Society, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and MetabolismEpilepsia, 2007
- Adverse Effects of Antiepileptic Drugs on Bone Mineral DensityPediatric Neurology, 2006
- Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaJournal of Clinical Investigation, 2006
- Effect of carbamazepine and valproate on bone mineral densityPediatric Neurology, 2004
- Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in BoneBiochemical and Biophysical Research Communications, 1995
- Reversible Fanconi syndrome associated with valproate therapyThe Journal of Pediatrics, 1993
- The effect of phenytoin on parathyroid hormone stimulated cAMP activity in cultured murine osteoblastsLife Sciences, 1990
- Effects of parathyroid hormone on cAMP production and alkaline phosphatase activity in osteoblastic clone MC3T3-E1 cellsBiochemical and Biophysical Research Communications, 1984